Section 12 AAC 52.460 - Prescription drug order information(a) Before a pharmacist may fill a prescription drug order, the pharmacist shall obtain the following information: (1) name of the patient or, if the prescription drug order is for an animal, species of the animal and name of the owner;(2) address of the patient unless the prescription drug order is for a noncontrolled substance and the address is readily retrievable on another appropriate, uniformly maintained pharmacy record, such as a patient medication record;(3) name and, if the prescription drug order is for a controlled substance, the address and DEA registration number of the prescribing practitioner;(4) name and strength of the drug prescribed;(8) refills authorized, if any;(9) if a written or hard copy prescription drug order, the prescribing practitioner's handwritteg, digital, electronic, or stamped signature;(10) if a prescription drug order is received by the pharmacy as a facsimile, the prescribing practitioner's handwritten, digital, electronic, or stamped signature or authorized agent's signature; and(11) if the rescrition drug order is signed by an authorized agent, the name of the prescribing practitioner. (b) At the time of dispensing, a pharmacist shall add the following information to the prescription drug order: (1) unique identification number of the prescription drug order;(2) initials or identification code of the dispensing pharmacist;(3) quantity dispensed, if different from the quantity prescribed;(4) date of dispensing, if different from the date of issue;(5) if the drug was prescribed by generic name or if an equivalent drug product other than the one prescribed was dispensed, for the drug product actually dispensed, at least one of the following: (A) the name of the drug product's manufacturer or distributor;(B) the national drug code number;(C) the short name code; or(c) After oral consultation with the prescribing practitioner, a pharmacist may add the following information to schedule II controlled substance prescriptions: (1) date of issue of the prescription;(2) address of the patient;(3) strength of the drug prescribed;(5) drug quantity prescribed;(7) DEA registration number.(d) After oral consultation with the prescribing practitioner, a pharmacist may modify the types of information described in (c)(2) - (7) of this section. However, any modification to the information concerning drug quantity must be limited to strength of the drug prescribed and may not result in an increase in the original total dosage prescribed.(e) A pharmacist may not change the name of non-generic drugs, the name of the patient, or the signature of the practitioner.Eff. 1/16/98, Register 145; am 9/11/2010, Register 195; am 9/17/2011, Register 199; am 11/16/2012, Register 204; am 7/9/2017,Register 223, October 2017Authority:AS 08.80.005
AS 08.80.030